Clinical trial

Role of the Serum Exosomal miRNA in Diabetic Retinopathy (DR)

NCT03264976

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention hematological examination, ophthalmic examination Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Role of the Serum Exosomal miRNA in Diabetic Retinopathy (DR)

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2018-07-01

PhaseN/A

Conditions

Diabetic Retinopathyverified · MONDO: diabetic retinopathy

Interventions

hematological examination, ophthalmic examinationDIAGNOSTIC_TEST

Sponsors & collaborators

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03264976 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.